Company Overview More
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, an NPR-A and NPR-binder to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was incorporated in 1986 and is based in Cranbury, New Jersey.
CEO: Spana Ph.D., Carl
Market: AMEX
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

Moomoo > Quotes > PTN Palatin Technologies > Detailed Quotes

PTN Palatin Technologies

0.558+0.043+8.40%
Close 11/26 16:55 ET
0.802+0.2445+43.85%
Post Mkt Price 11/26 16:59 ET
High
0.558
Open
0.466
Turnover
29.74M
Low
0.460
Prev.Close
0.514
Volume
41.87M
Market Cap
129.00M
P/E(TTM)
Loss
52Wk High
1.300
Shares
231.35M
P/E
Loss
52Wk Low
0.330
H Mkt Cap
126.59M
Bid-Ask Ratio
39.53%
Historical High
107.500
H Shares
227.02M
Vol. Ratio
1.79
Historical Low
0.285
Dividend TTM
--
Div Yield TTM
--
P/B
3.00
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
18.44%
Amplitude
18.97%
Avg Price
0.710
Min Trading Unit
1
Float Market Cap
126.59M
Bid-Ask Ratio
39.53%
Historical High
107.500
Float
227.02M
Vol. Ratio
1.79
Historical Low
0.285
Dividend TTM
--
P/B
3.00
Dividend LFY
--
Turnover Ratio
18.44%
Amplitude
18.97%
Avg Price
0.710
Min Trading Unit
1
Price Forecast

Loading...

News